Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Immunotherapy Leaders' Forum 2012

LAKE OSWEGO, Ore., May 9, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical...
May 08, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present Updated NeuVax(TM) Results at ASCO (American Society of Clinical Oncology) 2012 Annual Meeting

NeuVax™ (E75) presentation entitled, "Safety and Long-Term Maintenance of Anti-HER2 Immunity Following Booster Inoculations of the E75 Breast Cancer Vaccine." Galena to host panel...
May 03, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Strengthens Clinical Management Team

LAKE OSWEGO, Ore., May 3, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical...
May 01, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Expands Folate Binding Protein Vaccine Intellectual Property With Notice of Allowance for U.S. Patent

Composition of Matter patent covers FBP peptide variants for individual or expanded use in combination with the FBP vaccine, E39. Provides exclusivity until 2029, not including any patent...
April 26, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Takes Final Actions to Complete Spin-Off of RXi Pharmaceuticals

One-for-one RXi Pharmaceuticals stock dividend to be paid to Galena stockholders as of the payment date of April 26, 2012 Galena to retain minority equity interest in RXi, with potential to...
April 16, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Exercise of Underwriters' Over-Allotment Option and Closing of $14.5 Million Public Offering of Common Stock

LAKE OSWEGO, Ore., April 16, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 10, 2012 04:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the World Vaccine Trials Congress

LAKE OSWEGO, Ore., April 10, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 05, 2012 08:37 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Public Offering of Common Stock

LAKE OSWEGO, Ore., April 5, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 04, 2012 16:23 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Public Offering of Common Stock

LAKE OSWEGO, Ore., April 4, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
March 28, 2012 18:03 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Fourth Quarter and 2011 Financial Results and Provides Business Update

LAKE OSWEGO, Ore., March 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...